{"transactions":[{"id":702139,"issuer":{"id":6636,"kind":"organization","name":"Vivani Medical, Inc."},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-07-28T22:48:15.000Z","date":"2026-07-27","kind":"grant","planned":false,"acquired":true,"shares":7965,"price":1.3,"value":10354.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Awarded pursuant to the Issuer's non-employee director compensation policy in lieu of cash retainer fees of $8,000, provided in consideration for increased committee service."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options have a 10-year term and vests quarterly through December 31, 2026, subject to the Reporting Person's continued service through each such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Awarded pursuant to the Issuer's non-employee director compensation policy in lieu of cash retainer fees of $8,000, provided in consideration for increased committee service."}],"balance_after":7965,"derivative":{"exercise_price":1.3,"expiration_date":"2026-07-26","underlying":"Common Stock","underlying_shares":7965},"source":{"system":"sec-edgar","filing":"0001753926-26-001243","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266806/000175392626001243/form4.xml","form_type":"4"}},{"id":726282,"issuer":{"id":6636,"kind":"organization","name":"Vivani Medical, Inc."},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-06-25T23:40:13.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":36516,"price":1.22,"value":44549.52,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option vests in total on the earlier of (i) the first anniversary of the grant or (ii) the next annual meeting of stockholders, subject to continued service through such date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Annual grant awarded pursuant to the Issuer's Non-Employee Director Compensation Policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in total on the earlier of (i) the first anniversary of the grant or (ii) the next annual meeting of stockholders, subject to continued service through such date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"The option vests in total on the earlier of (i) the first anniversary of the grant or (ii) the next annual meeting of stockholders, subject to continued service through such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The option vests in total on the earlier of (i) the first anniversary of the grant or (ii) the next annual meeting of stockholders, subject to continued service through such date."}],"balance_after":36516,"derivative":{"exercise_price":1.22,"expiration_date":"2036-06-23","underlying":"Common Stock","underlying_shares":36516},"source":{"system":"sec-edgar","filing":"0001753926-26-001069","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266806/000175392626001069/form4.xml","form_type":"4"}},{"id":756937,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-01T20:44:17.000Z","date":"2026-05-28","kind":"grant","planned":false,"acquired":true,"shares":11766,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in full on the earlier of the (a) one-year anniversary of the date on May 28, 2027, or (b) the day immediately preceding the next Annual Meeting of Stockholders following the date of the grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in full on the earlier of the (a) one-year anniversary of the date on May 28, 2027, or (b) the day immediately preceding the next Annual Meeting of Stockholders following the date of the grant."}],"balance_after":11766,"derivative":{"underlying":"Common Stock","underlying_shares":11766},"source":{"system":"sec-edgar","filing":"0001628280-26-039554","document":"wk-form4_1780346654.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000162828026039554/wk-form4_1780346654.xml","form_type":"4"}},{"id":758592,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN"}}],"security":"Director stock option (right to buy)","published_at":"2026-05-29T22:23:18.000Z","date":"2026-05-28","kind":"grant","planned":false,"acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in twelve equal monthly installments commencing on the grant date of May 28, 2026, provided that the option will, in any case, be fully vested on the date of the Issuer's annual meeting of stockholders following the grant date."}],"balance_after":70000,"derivative":{"exercise_price":2.84,"expiration_date":"2036-05-27","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001236397-26-000003","document":"form4-05292026_100514.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236397/000123639726000003/form4-05292026_100514.xml","form_type":"4"}},{"id":761652,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-05-27T20:18:47.000Z","date":"2026-05-22","kind":"exercise","planned":false,"acquired":false,"shares":13667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in full on the earlier of the (a) one-year anniversary of the date on May 22, 2026, or (b) the day immediately preceding the next Annual Meeting of Stockholders following the date of\nthe grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in full on the earlier of the (a) one-year anniversary of the date on May 22, 2026, or (b) the day immediately preceding the next Annual Meeting of Stockholders following the date of\nthe grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":13667},"source":{"system":"sec-edgar","filing":"0001628280-26-038476","document":"wk-form4_1779913124.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000162828026038476/wk-form4_1779913124.xml","form_type":"4"}},{"id":761651,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-27T20:18:47.000Z","date":"2026-05-22","kind":"exercise","planned":false,"acquired":true,"shares":13667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's Common Stock."}],"balance_after":22340,"source":{"system":"sec-edgar","filing":"0001628280-26-038476","document":"wk-form4_1779913124.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000162828026038476/wk-form4_1779913124.xml","form_type":"4"}},{"id":950708,"issuer":{"id":6636,"kind":"organization","name":"Vivani Medical, Inc."},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-01-05T23:50:12.000Z","date":"2026-01-01","kind":"grant","planned":false,"acquired":true,"shares":47212,"price":1.23,"value":58070.76,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Awarded pursuant to the Issuer's non-employee director compensation policy in lieu of cash retainer fees of $45,000."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options have a 10-year term and vests quarterly through December 31, 2026, subject to the Reporting Person's continued service through each such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Awarded pursuant to the Issuer's non-employee director compensation policy in lieu of cash retainer fees of $45,000."}],"balance_after":47212,"derivative":{"exercise_price":1.23,"expiration_date":"2035-12-31","underlying":"Common Stock","underlying_shares":47212},"source":{"system":"sec-edgar","filing":"0001753926-26-000045","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266806/000175392626000045/form4.xml","form_type":"4"}},{"id":1100955,"issuer":{"id":6636,"kind":"organization","name":"Vivani Medical, Inc."},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-06-26T23:23:09.000Z","date":"2025-01-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":237,"price":1.16,"value":274.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Reflects an adjustment to a previously reported amount grant on 01/01/2025 from 50,059 to 49,822 due to a clerical error."},{"field":"shares","element":"transactionShares","label":"F3","text":"Reflects an adjustment to a previously reported amount grant on 01/01/2025 from 50,059 to 49,822 due to a clerical error."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option will vest one-fourth at the end of each calendar quarter following the grant date, subject to continued service through each such date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"Reflects an adjustment to a previously reported amount grant on 01/01/2025 from 50,059 to 49,822 due to a clerical error."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects an adjustment to a previously reported amount grant on 01/01/2025 from 50,059 to 49,822 due to a clerical error."}],"balance_after":49822,"derivative":{"exercise_price":1.16,"expiration_date":"2034-12-31","underlying":"Common Stock","underlying_shares":237},"source":{"system":"sec-edgar","filing":"0001753926-25-001027","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1266806/000175392625001027/form4.xml","form_type":"4"}},{"id":1100954,"issuer":{"id":6636,"kind":"organization","name":"Vivani Medical, Inc."},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-06-26T23:23:09.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":35135,"price":1.27,"value":44621.45,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option vests in total on the earlier of (i) the first anniversary of the grant or (ii) the next annual meeting of stockholders, subject to continued service through such date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Annual grant awarded pursuant to the Issuer's Non-Employee Director Compensation Policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in total on the earlier of (i) the first anniversary of the grant or (ii) the next annual meeting of stockholders, subject to continued service through such date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"The option vests in total on the earlier of (i) the first anniversary of the grant or (ii) the next annual meeting of stockholders, subject to continued service through such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The option vests in total on the earlier of (i) the first anniversary of the grant or (ii) the next annual meeting of stockholders, subject to continued service through such date."}],"balance_after":35135,"derivative":{"exercise_price":1.27,"expiration_date":"2035-06-23","underlying":"Common Stock","underlying_shares":35135},"source":{"system":"sec-edgar","filing":"0001753926-25-001027","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266806/000175392625001027/form4.xml","form_type":"4"}},{"id":1135185,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-05-23T20:19:15.000Z","date":"2025-05-22","kind":"grant","planned":false,"acquired":true,"shares":13667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vest in full on the earlier of the (a) one-year anniversary of the date on May 22, 2026, or (b) the day immediately preceding the next Annual Meeting of Stockholders following the date of\nthe grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vest in full on the earlier of the (a) one-year anniversary of the date on May 22, 2026, or (b) the day immediately preceding the next Annual Meeting of Stockholders following the date of\nthe grant."}],"balance_after":13667,"derivative":{"underlying":"Common Stock","underlying_shares":13667},"source":{"system":"sec-edgar","filing":"0001447362-25-000084","document":"wk-form4_1748031546.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736225000084/wk-form4_1748031546.xml","form_type":"4"}},{"id":1135184,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-05-23T20:19:15.000Z","date":"2025-05-21","kind":"exercise","planned":false,"acquired":false,"shares":8673,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in full on the earlier of the (a) one-year anniversary of the date on May 23, 2025, or (b) the day immediately preceding the next Annual Meeting of Stockholders following the date of\nthe grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in full on the earlier of the (a) one-year anniversary of the date on May 23, 2025, or (b) the day immediately preceding the next Annual Meeting of Stockholders following the date of\nthe grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8673},"source":{"system":"sec-edgar","filing":"0001447362-25-000084","document":"wk-form4_1748031546.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736225000084/wk-form4_1748031546.xml","form_type":"4"}},{"id":1135183,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-23T20:19:15.000Z","date":"2025-05-21","kind":"exercise","planned":false,"acquired":true,"shares":8673,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's Common Stock."}],"balance_after":8673,"source":{"system":"sec-edgar","filing":"0001447362-25-000084","document":"wk-form4_1748031546.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736225000084/wk-form4_1748031546.xml","form_type":"4"}},{"id":1259255,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"EXECUTIVE CHAIRMAN"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-02-20T00:42:33.000Z","date":"2025-02-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023.  All of the other terms of the options remained unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years."}],"balance_after":0,"derivative":{"exercise_price":1.06,"expiration_date":"2033-01-02","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-25-004761","document":"form4-02202025_120229.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1236397/000141588925004761/form4-02202025_120229.xml","form_type":"4"}},{"id":1259254,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"EXECUTIVE CHAIRMAN"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-02-20T00:42:33.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023.  All of the other terms of the options remained unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years."}],"balance_after":50000,"derivative":{"exercise_price":0.785,"expiration_date":"2033-01-02","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-25-004761","document":"form4-02202025_120229.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1236397/000141588925004761/form4-02202025_120229.xml","form_type":"4"}},{"id":1259253,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"EXECUTIVE CHAIRMAN"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-02-20T00:42:33.000Z","date":"2025-02-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":38000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023.  All of the other terms of the options remained unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years."}],"balance_after":0,"derivative":{"exercise_price":3.59,"expiration_date":"2032-02-29","underlying":"Common Stock","underlying_shares":38000},"source":{"system":"sec-edgar","filing":"0001415889-25-004761","document":"form4-02202025_120229.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1236397/000141588925004761/form4-02202025_120229.xml","form_type":"4"}},{"id":1259252,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"EXECUTIVE CHAIRMAN"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-02-20T00:42:33.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":38000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023.  All of the other terms of the options remained unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years."}],"balance_after":38000,"derivative":{"exercise_price":0.785,"expiration_date":"2032-02-29","underlying":"Common Stock","underlying_shares":38000},"source":{"system":"sec-edgar","filing":"0001415889-25-004761","document":"form4-02202025_120229.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1236397/000141588925004761/form4-02202025_120229.xml","form_type":"4"}},{"id":1259251,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"EXECUTIVE CHAIRMAN"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-02-20T00:42:33.000Z","date":"2025-02-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":36000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023.  All of the other terms of the options remained unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years."}],"balance_after":0,"derivative":{"exercise_price":5.03,"expiration_date":"2031-01-03","underlying":"Common Stock","underlying_shares":36000},"source":{"system":"sec-edgar","filing":"0001415889-25-004761","document":"form4-02202025_120229.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1236397/000141588925004761/form4-02202025_120229.xml","form_type":"4"}},{"id":1259250,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"EXECUTIVE CHAIRMAN"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-02-20T00:42:33.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":36000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023.  All of the other terms of the options remained unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years."}],"balance_after":36000,"derivative":{"exercise_price":0.785,"expiration_date":"2031-01-03","underlying":"Common Stock","underlying_shares":36000},"source":{"system":"sec-edgar","filing":"0001415889-25-004761","document":"form4-02202025_120229.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1236397/000141588925004761/form4-02202025_120229.xml","form_type":"4"}},{"id":1259249,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"EXECUTIVE CHAIRMAN"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-02-20T00:42:33.000Z","date":"2025-02-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":28708,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023.  All of the other terms of the options remained unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option became fully vested on the grant date of May 28, 2020."}],"balance_after":0,"derivative":{"exercise_price":3.53,"expiration_date":"2030-05-27","underlying":"Common Stock","underlying_shares":28708},"source":{"system":"sec-edgar","filing":"0001415889-25-004761","document":"form4-02202025_120229.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1236397/000141588925004761/form4-02202025_120229.xml","form_type":"4"}},{"id":1259248,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"EXECUTIVE CHAIRMAN"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-02-20T00:42:33.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":28708,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023.  All of the other terms of the options remained unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option became fully vested on the grant date of May 28, 2020."}],"balance_after":28708,"derivative":{"exercise_price":0.785,"expiration_date":"2030-05-27","underlying":"Common Stock","underlying_shares":28708},"source":{"system":"sec-edgar","filing":"0001415889-25-004761","document":"form4-02202025_120229.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1236397/000141588925004761/form4-02202025_120229.xml","form_type":"4"}},{"id":1259247,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"EXECUTIVE CHAIRMAN"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-02-20T00:42:33.000Z","date":"2025-02-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":36000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023.  All of the other terms of the options remained unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years."}],"balance_after":0,"derivative":{"exercise_price":4.75,"expiration_date":"2029-12-09","underlying":"Common Stock","underlying_shares":36000},"source":{"system":"sec-edgar","filing":"0001415889-25-004761","document":"form4-02202025_120229.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1236397/000141588925004761/form4-02202025_120229.xml","form_type":"4"}},{"id":1259246,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"EXECUTIVE CHAIRMAN"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-02-20T00:42:33.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":36000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023.  All of the other terms of the options remained unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years."}],"balance_after":36000,"derivative":{"exercise_price":0.785,"expiration_date":"2029-12-09","underlying":"Common Stock","underlying_shares":36000},"source":{"system":"sec-edgar","filing":"0001415889-25-004761","document":"form4-02202025_120229.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1236397/000141588925004761/form4-02202025_120229.xml","form_type":"4"}},{"id":1259245,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"EXECUTIVE CHAIRMAN"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-02-20T00:42:33.000Z","date":"2025-02-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":90000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023.  All of the other terms of the options remained unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years."}],"balance_after":0,"derivative":{"exercise_price":7.16,"expiration_date":"2029-02-12","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001415889-25-004761","document":"form4-02202025_120229.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1236397/000141588925004761/form4-02202025_120229.xml","form_type":"4"}},{"id":1259244,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"EXECUTIVE CHAIRMAN"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-02-20T00:42:33.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":90000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023.  All of the other terms of the options remained unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years."}],"balance_after":90000,"derivative":{"exercise_price":0.785,"expiration_date":"2029-02-12","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001415889-25-004761","document":"form4-02202025_120229.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236397/000141588925004761/form4-02202025_120229.xml","form_type":"4"}},{"id":1278632,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-07T21:12:40.000Z","date":"2025-02-05","kind":"sale","planned":true,"acquired":false,"shares":1425,"price":28.173,"value":40146.525,"ownership":{"direct":false,"nature":"By Annette Bradbury Irrevocable Descendant's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, Daniel Bradbury Irrevocable Descendant's Trust, and Annette Bradbury Irrevocable Descendant's Trust on May 10, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $28.060 to $28.585, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Held by Annette Bradbury Irrevocable Descendant's Trust of which the Reporting Person and his spouse are trustees and their children are beneficiaries."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001447362-25-000016","document":"wk-form4_1738962754.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736225000016/wk-form4_1738962754.xml","form_type":"4"}},{"id":1278631,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-07T21:12:40.000Z","date":"2025-02-05","kind":"sale","planned":true,"acquired":false,"shares":1425,"price":28.173,"value":40146.525,"ownership":{"direct":false,"nature":"By Daniel Bradbury Irrevocable Descendant's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, Daniel Bradbury Irrevocable Descendant's Trust, and Annette Bradbury Irrevocable Descendant's Trust on May 10, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $28.060 to $28.585, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Held by Daniel Bradbury Irrevocable Descendant's Trust of which the Reporting Person and his spouse are trustees and their children are beneficiaries."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001447362-25-000016","document":"wk-form4_1738962754.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736225000016/wk-form4_1738962754.xml","form_type":"4"}},{"id":1278630,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-07T21:12:40.000Z","date":"2025-02-05","kind":"sale","planned":true,"acquired":false,"shares":5017,"price":28.173,"value":141343.941,"ownership":{"direct":false,"nature":"By LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, Daniel Bradbury Irrevocable Descendant's Trust, and Annette Bradbury Irrevocable Descendant's Trust on May 10, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $28.060 to $28.585, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Held by BioBrit, LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001447362-25-000016","document":"wk-form4_1738962754.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736225000016/wk-form4_1738962754.xml","form_type":"4"}},{"id":1306541,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-08T23:19:37.000Z","date":"2025-01-06","kind":"sale","planned":true,"acquired":false,"shares":134,"price":29.82,"value":3995.88,"ownership":{"direct":false,"nature":"By Annette Bradbury Irrevocable Descendant's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, Daniel Bradbury Irrevocable Descendant's Trust, and Annette Bradbury Irrevocable Descendant's Trust on May 10, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $29.78 to $29.87, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Held by Annette Bradbury Irrevocable Descendant's Trust of which the Reporting Person and his spouse are trustees and their children are beneficiaries."}],"balance_after":1425,"source":{"system":"sec-edgar","filing":"0001447362-25-000008","document":"wk-form4_1736378371.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736225000008/wk-form4_1736378371.xml","form_type":"4"}},{"id":1306540,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-08T23:19:37.000Z","date":"2025-01-06","kind":"sale","planned":true,"acquired":false,"shares":134,"price":29.82,"value":3995.88,"ownership":{"direct":false,"nature":"By Daniel Bradbury Irrevocable Descendant's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, Daniel Bradbury Irrevocable Descendant's Trust, and Annette Bradbury Irrevocable Descendant's Trust on May 10, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $29.78 to $29.87, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Held by Daniel Bradbury Irrevocable Descendant's Trust of which the Reporting Person and his spouse are trustees and their children are beneficiaries."}],"balance_after":1425,"source":{"system":"sec-edgar","filing":"0001447362-25-000008","document":"wk-form4_1736378371.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736225000008/wk-form4_1736378371.xml","form_type":"4"}},{"id":1306539,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-08T23:19:37.000Z","date":"2025-01-06","kind":"sale","planned":true,"acquired":false,"shares":472,"price":29.82,"value":14075.04,"ownership":{"direct":false,"nature":"By LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, Daniel Bradbury Irrevocable Descendant's Trust, and Annette Bradbury Irrevocable Descendant's Trust on May 10, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $29.78 to $29.87, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Held by BioBrit, LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares."}],"balance_after":5017,"source":{"system":"sec-edgar","filing":"0001447362-25-000008","document":"wk-form4_1736378371.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736225000008/wk-form4_1736378371.xml","form_type":"4"}},{"id":1306538,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-08T23:19:37.000Z","date":"2025-01-06","kind":"sale","planned":true,"acquired":false,"shares":857,"price":29.41,"value":25204.37,"ownership":{"direct":false,"nature":"By Annette Bradbury Irrevocable Descendant's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, Daniel Bradbury Irrevocable Descendant's Trust, and Annette Bradbury Irrevocable Descendant's Trust on May 10, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $28.84 to $29.77, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Held by Annette Bradbury Irrevocable Descendant's Trust of which the Reporting Person and his spouse are trustees and their children are beneficiaries."}],"balance_after":1559,"source":{"system":"sec-edgar","filing":"0001447362-25-000008","document":"wk-form4_1736378371.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736225000008/wk-form4_1736378371.xml","form_type":"4"}},{"id":1306537,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-08T23:19:37.000Z","date":"2025-01-06","kind":"sale","planned":true,"acquired":false,"shares":857,"price":29.41,"value":25204.37,"ownership":{"direct":false,"nature":"By Daniel Bradbury Irrevocable Descendant's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, Daniel Bradbury Irrevocable Descendant's Trust, and Annette Bradbury Irrevocable Descendant's Trust on May 10, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $28.84 to $29.77, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Held by Daniel Bradbury Irrevocable Descendant's Trust of which the Reporting Person and his spouse are trustees and their children are beneficiaries."}],"balance_after":1559,"source":{"system":"sec-edgar","filing":"0001447362-25-000008","document":"wk-form4_1736378371.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736225000008/wk-form4_1736378371.xml","form_type":"4"}},{"id":1306536,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-08T23:19:37.000Z","date":"2025-01-06","kind":"sale","planned":true,"acquired":false,"shares":3015,"price":29.41,"value":88671.15,"ownership":{"direct":false,"nature":"By LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, Daniel Bradbury Irrevocable Descendant's Trust, and Annette Bradbury Irrevocable Descendant's Trust on May 10, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $28.84 to $29.77, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Held by BioBrit, LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares."}],"balance_after":5489,"source":{"system":"sec-edgar","filing":"0001447362-25-000008","document":"wk-form4_1736378371.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736225000008/wk-form4_1736378371.xml","form_type":"4"}},{"id":1306535,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-08T23:19:37.000Z","date":"2025-01-06","kind":"sale","planned":true,"acquired":false,"shares":434,"price":28.39,"value":12321.26,"ownership":{"direct":false,"nature":"By Annette Bradbury Irrevocable Descendant's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, Daniel Bradbury Irrevocable Descendant's Trust, and Annette Bradbury Irrevocable Descendant's Trust on May 10, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $27.78 to $28.73, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Held by Annette Bradbury Irrevocable Descendant's Trust of which the Reporting Person and his spouse are trustees and their children are beneficiaries."}],"balance_after":2416,"source":{"system":"sec-edgar","filing":"0001447362-25-000008","document":"wk-form4_1736378371.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736225000008/wk-form4_1736378371.xml","form_type":"4"}},{"id":1306534,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-08T23:19:37.000Z","date":"2025-01-06","kind":"sale","planned":true,"acquired":false,"shares":434,"price":28.39,"value":12321.26,"ownership":{"direct":false,"nature":"By Daniel Bradbury Irrevocable Descendant's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, Daniel Bradbury Irrevocable Descendant's Trust, and Annette Bradbury Irrevocable Descendant's Trust on May 10, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $27.78 to $28.73, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Held by Daniel Bradbury Irrevocable Descendant's Trust of which the Reporting Person and his spouse are trustees and their children are beneficiaries."}],"balance_after":2416,"source":{"system":"sec-edgar","filing":"0001447362-25-000008","document":"wk-form4_1736378371.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736225000008/wk-form4_1736378371.xml","form_type":"4"}},{"id":1306533,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-08T23:19:37.000Z","date":"2025-01-06","kind":"sale","planned":true,"acquired":false,"shares":1530,"price":28.39,"value":43436.7,"ownership":{"direct":false,"nature":"By LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, Daniel Bradbury Irrevocable Descendant's Trust, and Annette Bradbury Irrevocable Descendant's Trust on May 10, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $27.78 to $28.73, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Held by BioBrit, LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares."}],"balance_after":8504,"source":{"system":"sec-edgar","filing":"0001447362-25-000008","document":"wk-form4_1736378371.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736225000008/wk-form4_1736378371.xml","form_type":"4"}},{"id":1310120,"issuer":{"id":6560,"kind":"organization","name":"Equillium, Inc."},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"EXECUTIVE CHAIRMAN"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-01-06T23:21:55.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years."}],"balance_after":50000,"derivative":{"exercise_price":0.77,"expiration_date":"2035-01-01","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-25-000852","document":"form4-01062025_110151.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236397/000141588925000852/form4-01062025_110151.xml","form_type":"4"}},{"id":1314105,"issuer":{"id":6636,"kind":"organization","name":"Vivani Medical, Inc."},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-01-04T01:06:43.000Z","date":"2025-01-01","kind":"grant","planned":false,"acquired":true,"shares":50059,"price":1.16,"value":58068.44,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Awarded pursuant to the Issuer's non-employee director compensation policy in lieu of cash retainer fees of $45,000."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options have a 10-year term and vests quarterly through December 31, 2025, subject to continued service through each such date"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Awarded pursuant to the Issuer's non-employee director compensation policy in lieu of cash retainer fees of $45,000."}],"balance_after":50059,"derivative":{"exercise_price":1.16,"expiration_date":"2034-12-31","underlying":"Common Stock","underlying_shares":50059},"source":{"system":"sec-edgar","filing":"0001753926-25-000017","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266806/000175392625000017/primary_doc.xml","form_type":"4"}},{"id":1341504,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-05T21:28:43.000Z","date":"2024-12-03","kind":"sale","planned":true,"acquired":false,"shares":99,"price":31.32,"value":3100.68,"ownership":{"direct":false,"nature":"By Annette Bradbury Irrecovable Descendant's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by Daniel Bradbury on May 10, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $31.30 to $31.34, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Held by Annette Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries."}],"balance_after":2850,"source":{"system":"sec-edgar","filing":"0001447362-24-000190","document":"wk-form4_1733434115.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736224000190/wk-form4_1733434115.xml","form_type":"4"}},{"id":1341503,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-05T21:28:43.000Z","date":"2024-12-03","kind":"sale","planned":true,"acquired":false,"shares":99,"price":31.32,"value":3100.68,"ownership":{"direct":false,"nature":"By Daniel Bradbury Irrecovable Descendant's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by Daniel Bradbury on May 10, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $31.30 to $31.34, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Held by Daniel Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries."}],"balance_after":2850,"source":{"system":"sec-edgar","filing":"0001447362-24-000190","document":"wk-form4_1733434115.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736224000190/wk-form4_1733434115.xml","form_type":"4"}},{"id":1341502,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-05T21:28:43.000Z","date":"2024-12-03","kind":"sale","planned":true,"acquired":false,"shares":348,"price":31.32,"value":10899.36,"ownership":{"direct":false,"nature":"By LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by Daniel Bradbury on May 10, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $31.30 to $31.34, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Held by BioBrit, LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares."}],"balance_after":10034,"source":{"system":"sec-edgar","filing":"0001447362-24-000190","document":"wk-form4_1733434115.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736224000190/wk-form4_1733434115.xml","form_type":"4"}},{"id":1341501,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-05T21:28:43.000Z","date":"2024-12-03","kind":"sale","planned":true,"acquired":false,"shares":1326,"price":30.951,"value":41041.026,"ownership":{"direct":false,"nature":"By Annette Bradbury Irrecovable Descendant's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by Daniel Bradbury on May 10, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $30.300 to $31.275, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Held by Annette Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries."}],"balance_after":2949,"source":{"system":"sec-edgar","filing":"0001447362-24-000190","document":"wk-form4_1733434115.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736224000190/wk-form4_1733434115.xml","form_type":"4"}},{"id":1341500,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-05T21:28:43.000Z","date":"2024-12-03","kind":"sale","planned":true,"acquired":false,"shares":1326,"price":30.951,"value":41041.026,"ownership":{"direct":false,"nature":"By Daniel Bradbury Irrecovable Descendant's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by Daniel Bradbury on May 10, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $30.300 to $31.275, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Held by Daniel Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries."}],"balance_after":2949,"source":{"system":"sec-edgar","filing":"0001447362-24-000190","document":"wk-form4_1733434115.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736224000190/wk-form4_1733434115.xml","form_type":"4"}},{"id":1341499,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-05T21:28:43.000Z","date":"2024-12-03","kind":"sale","planned":true,"acquired":false,"shares":4669,"price":30.951,"value":144510.219,"ownership":{"direct":false,"nature":"By LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by Daniel Bradbury on May 10, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $30.300 to $31.275, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Held by BioBrit, LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares."}],"balance_after":10382,"source":{"system":"sec-edgar","filing":"0001447362-24-000190","document":"wk-form4_1733434115.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736224000190/wk-form4_1733434115.xml","form_type":"4"}},{"id":1375292,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-05T21:32:34.000Z","date":"2024-11-01","kind":"sale","planned":true,"acquired":false,"shares":287,"price":35.33,"value":10139.71,"ownership":{"direct":false,"nature":"By Annette Bradbury Irrecovable Descendant's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by Daniel Bradbury on May 10, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $35.31 to $35.38, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Held by Annette Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries."}],"balance_after":4275,"source":{"system":"sec-edgar","filing":"0001447362-24-000172","document":"wk-form4_1730842347.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736224000172/wk-form4_1730842347.xml","form_type":"4"}},{"id":1375291,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-05T21:32:34.000Z","date":"2024-11-01","kind":"sale","planned":true,"acquired":false,"shares":287,"price":35.33,"value":10139.71,"ownership":{"direct":false,"nature":"By Daniel Bradbury Irrecovable Descendant's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by Daniel Bradbury on May 10, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $35.31 to $35.38, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Held by Daniel Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries."}],"balance_after":4275,"source":{"system":"sec-edgar","filing":"0001447362-24-000172","document":"wk-form4_1730842347.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736224000172/wk-form4_1730842347.xml","form_type":"4"}},{"id":1375290,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-05T21:32:34.000Z","date":"2024-11-01","kind":"sale","planned":true,"acquired":false,"shares":1009,"price":35.33,"value":35647.97,"ownership":{"direct":false,"nature":"By LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by Daniel Bradbury on May 10, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $35.31 to $35.38, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Held by BioBrit, LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares."}],"balance_after":15051,"source":{"system":"sec-edgar","filing":"0001447362-24-000172","document":"wk-form4_1730842347.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736224000172/wk-form4_1730842347.xml","form_type":"4"}},{"id":1375289,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-05T21:32:34.000Z","date":"2024-11-01","kind":"sale","planned":true,"acquired":false,"shares":763,"price":34.92,"value":26643.96,"ownership":{"direct":false,"nature":"By Annette Bradbury Irrecovable Descendant's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by Daniel Bradbury on May 10, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $34.35 to $35.30, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Held by Annette Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries."}],"balance_after":4562,"source":{"system":"sec-edgar","filing":"0001447362-24-000172","document":"wk-form4_1730842347.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736224000172/wk-form4_1730842347.xml","form_type":"4"}},{"id":1375288,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-05T21:32:34.000Z","date":"2024-11-01","kind":"sale","planned":true,"acquired":false,"shares":763,"price":34.92,"value":26643.96,"ownership":{"direct":false,"nature":"By Daniel Bradbury Irrecovable Descendant's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by Daniel Bradbury on May 10, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $34.35 to $35.30, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Held by Daniel Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries."}],"balance_after":4562,"source":{"system":"sec-edgar","filing":"0001447362-24-000172","document":"wk-form4_1730842347.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736224000172/wk-form4_1730842347.xml","form_type":"4"}},{"id":1375287,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-05T21:32:34.000Z","date":"2024-11-01","kind":"sale","planned":true,"acquired":false,"shares":2686,"price":34.92,"value":93795.12,"ownership":{"direct":false,"nature":"By LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by Daniel Bradbury on May 10, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $34.35 to $35.30, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Held by BioBrit, LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares."}],"balance_after":16060,"source":{"system":"sec-edgar","filing":"0001447362-24-000172","document":"wk-form4_1730842347.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736224000172/wk-form4_1730842347.xml","form_type":"4"}},{"id":1375286,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-05T21:32:34.000Z","date":"2024-11-01","kind":"sale","planned":true,"acquired":false,"shares":375,"price":33.9,"value":12712.5,"ownership":{"direct":false,"nature":"By Annette Bradbury Irrecovable Descendant's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by Daniel Bradbury on May 10, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $33.30 to $34.28, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Held by Annette Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries."}],"balance_after":5325,"source":{"system":"sec-edgar","filing":"0001447362-24-000172","document":"wk-form4_1730842347.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736224000172/wk-form4_1730842347.xml","form_type":"4"}},{"id":1375285,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-05T21:32:34.000Z","date":"2024-11-01","kind":"sale","planned":true,"acquired":false,"shares":375,"price":33.9,"value":12712.5,"ownership":{"direct":false,"nature":"By Daniel Bradbury Irrecovable Descendant's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by Daniel Bradbury on May 10, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $33.30 to $34.28, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Held by Daniel Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries."}],"balance_after":5325,"source":{"system":"sec-edgar","filing":"0001447362-24-000172","document":"wk-form4_1730842347.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736224000172/wk-form4_1730842347.xml","form_type":"4"}},{"id":1375284,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-05T21:32:34.000Z","date":"2024-11-01","kind":"sale","planned":true,"acquired":false,"shares":1322,"price":33.9,"value":44815.8,"ownership":{"direct":false,"nature":"By LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by Daniel Bradbury on May 10, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $33.30 to $34.28, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Held by BioBrit, LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares."}],"balance_after":18746,"source":{"system":"sec-edgar","filing":"0001447362-24-000172","document":"wk-form4_1730842347.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736224000172/wk-form4_1730842347.xml","form_type":"4"}},{"id":1388563,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-09T20:30:52.000Z","date":"2024-10-07","kind":"sale","planned":true,"acquired":false,"shares":1425,"price":29.443,"value":41956.275,"ownership":{"direct":false,"nature":"By Annette Bradbury Irrecovable Descendant's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by Daniel Bradbury on May 10, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $29.18 to $29.79, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Held by Annette Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries."}],"balance_after":5700,"source":{"system":"sec-edgar","filing":"0001447362-24-000158","document":"wk-form4_1728505845.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736224000158/wk-form4_1728505845.xml","form_type":"4"}},{"id":1388562,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-09T20:30:52.000Z","date":"2024-10-07","kind":"sale","planned":true,"acquired":false,"shares":1425,"price":29.443,"value":41956.275,"ownership":{"direct":false,"nature":"By Daniel Bradbury Irrecovable Descendant's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by Daniel Bradbury on May 10, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $29.18 to $29.79, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Held by Daniel Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries."}],"balance_after":5700,"source":{"system":"sec-edgar","filing":"0001447362-24-000158","document":"wk-form4_1728505845.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736224000158/wk-form4_1728505845.xml","form_type":"4"}},{"id":1388561,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-09T20:30:52.000Z","date":"2024-10-07","kind":"sale","planned":true,"acquired":false,"shares":5017,"price":29.443,"value":147715.531,"ownership":{"direct":false,"nature":"By LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by Daniel Bradbury on May 10, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $29.18 to $29.79, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Held by BioBrit, LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares."}],"balance_after":20068,"source":{"system":"sec-edgar","filing":"0001447362-24-000158","document":"wk-form4_1728505845.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736224000158/wk-form4_1728505845.xml","form_type":"4"}},{"id":1411827,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-09T20:06:15.000Z","date":"2024-09-05","kind":"sale","planned":true,"acquired":false,"shares":1425,"price":29.024,"value":41359.2,"ownership":{"direct":false,"nature":"By Annette Bradbury Irrecovable Descendant's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by Daniel Bradbury on May 10, 2024."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Held by Annette Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries."}],"balance_after":7125,"source":{"system":"sec-edgar","filing":"0001447362-24-000146","document":"wk-form4_1725912368.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736224000146/wk-form4_1725912368.xml","form_type":"4"}},{"id":1411826,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-09T20:06:15.000Z","date":"2024-09-05","kind":"sale","planned":true,"acquired":false,"shares":1425,"price":29.024,"value":41359.2,"ownership":{"direct":false,"nature":"By Daniel Bradbury Irrecovable Descendant's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by Daniel Bradbury on May 10, 2024."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Held by Daniel Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries."}],"balance_after":7125,"source":{"system":"sec-edgar","filing":"0001447362-24-000146","document":"wk-form4_1725912368.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736224000146/wk-form4_1725912368.xml","form_type":"4"}},{"id":1411825,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-09T20:06:15.000Z","date":"2024-09-05","kind":"sale","planned":true,"acquired":false,"shares":5017,"price":29.024,"value":145613.408,"ownership":{"direct":false,"nature":"By LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by Daniel Bradbury on May 10, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $28.800 to $29.415, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Held by BioBrit, LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares."}],"balance_after":25085,"source":{"system":"sec-edgar","filing":"0001447362-24-000146","document":"wk-form4_1725912368.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736224000146/wk-form4_1725912368.xml","form_type":"4"}},{"id":1433561,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-14T20:53:14.000Z","date":"2024-08-12","kind":"sale","planned":true,"acquired":false,"shares":1431,"price":26.647,"value":38131.857,"ownership":{"direct":false,"nature":"By Annette Bradbury Irrecovable Descendant's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by Daniel Bradbury on May 10, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $26.31 to $27.23, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Held by Annette Bradbury Irrecovable Descendant's Trust of which the Reporting Person and his spouse are trustees and their children are beneficiaries."}],"balance_after":8550,"source":{"system":"sec-edgar","filing":"0001447362-24-000135","document":"wk-form4_1723668787.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736224000135/wk-form4_1723668787.xml","form_type":"4"}},{"id":1433560,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-14T20:53:14.000Z","date":"2024-08-12","kind":"sale","planned":true,"acquired":false,"shares":1431,"price":26.647,"value":38131.857,"ownership":{"direct":false,"nature":"By Daniel Bradbury Irrecovable Descendant's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by Daniel Bradbury on May 10, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $26.31 to $27.23, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Held by Daniel Bradbury Irrecovable Descendant's Trust of which the Reporting Person and his spouse are trustees and their children are beneficiaries."}],"balance_after":8550,"source":{"system":"sec-edgar","filing":"0001447362-24-000135","document":"wk-form4_1723668787.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736224000135/wk-form4_1723668787.xml","form_type":"4"}},{"id":1433559,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-14T20:53:14.000Z","date":"2024-08-12","kind":"sale","planned":true,"acquired":false,"shares":5021,"price":26.647,"value":133794.587,"ownership":{"direct":false,"nature":"By LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by Daniel Bradbury on May 10, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $26.31 to $27.23, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Held by BioBrit, LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares."}],"balance_after":30102,"source":{"system":"sec-edgar","filing":"0001447362-24-000135","document":"wk-form4_1723668787.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736224000135/wk-form4_1723668787.xml","form_type":"4"}},{"id":1465650,"issuer":{"id":6636,"kind":"organization","name":"Vivani Medical, Inc."},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Option","published_at":"2024-07-01T20:49:10.000Z","date":"2024-06-27","kind":"grant","planned":false,"acquired":true,"shares":34839,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Annual grant awarded pursuant to the Issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in total on the earlier of (i) the first anniversary of the grant and (ii) the next annual meeting of stockholders, subject to continued service through such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The option vests in total on the earlier of (i) the first anniversary of the grant and (ii) the next annual meeting of stockholders, subject to continued service through such date."}],"balance_after":34839,"derivative":{"exercise_price":1.27,"expiration_date":"2034-06-26","underlying":"Common Stock","underlying_shares":34839},"source":{"system":"sec-edgar","filing":"0001753926-24-001193","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266806/000175392624001193/ownership.xml","form_type":"4"}},{"id":1499073,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-05-29T20:46:37.000Z","date":"2024-05-25","kind":"exercise","planned":false,"acquired":false,"shares":8636,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested in full on the one-year anniversary of the date of grant on May 25, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested in full on the one-year anniversary of the date of grant on May 25, 2024."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8636},"source":{"system":"sec-edgar","filing":"0001447362-24-000098","document":"wk-form4_1717015589.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736224000098/wk-form4_1717015589.xml","form_type":"4"}},{"id":1499072,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-29T20:46:37.000Z","date":"2024-05-25","kind":"exercise","planned":false,"acquired":true,"shares":8636,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's Common Stock."}],"balance_after":13291,"source":{"system":"sec-edgar","filing":"0001447362-24-000098","document":"wk-form4_1717015589.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736224000098/wk-form4_1717015589.xml","form_type":"4"}},{"id":1500298,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-05-28T20:05:15.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":8673,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSU's vest in full on the one-year anniversary of the date of grant on May 23, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSU's vest in full on the one-year anniversary of the date of grant on May 23, 2025."}],"balance_after":8673,"derivative":{"underlying":"Common Stock","underlying_shares":8673},"source":{"system":"sec-edgar","filing":"0001447362-24-000074","document":"wk-form4_1716926703.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736224000074/wk-form4_1716926703.xml","form_type":"4"}},{"id":1523243,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-08T20:51:40.000Z","date":"2024-05-06","kind":"sale","planned":true,"acquired":false,"shares":7967,"price":24.64,"value":196306.88,"ownership":{"direct":false,"nature":"By Annette Bradbury Irrecovable Descendant's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on August 23, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $24.25 to $25.04, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Held by Annette Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries."}],"balance_after":9981,"source":{"system":"sec-edgar","filing":"0001447362-24-000064","document":"wk-form4_1715201475.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736224000064/wk-form4_1715201475.xml","form_type":"4"}},{"id":1523242,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-08T20:51:40.000Z","date":"2024-05-06","kind":"sale","planned":true,"acquired":false,"shares":7963,"price":24.64,"value":196208.32,"ownership":{"direct":false,"nature":"By Daniel Bradbury Irrecovable Descendant's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on August 23, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $24.25 to $25.04, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Held by Daniel Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries."}],"balance_after":9981,"source":{"system":"sec-edgar","filing":"0001447362-24-000064","document":"wk-form4_1715201475.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736224000064/wk-form4_1715201475.xml","form_type":"4"}},{"id":1523241,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-08T20:51:40.000Z","date":"2024-05-06","kind":"sale","planned":true,"acquired":false,"shares":7393,"price":24.64,"value":182163.52,"ownership":{"direct":false,"nature":"By LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on August 23, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $24.25 to $25.04, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Held by BioBrit, LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares."}],"balance_after":35123,"source":{"system":"sec-edgar","filing":"0001447362-24-000064","document":"wk-form4_1715201475.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736224000064/wk-form4_1715201475.xml","form_type":"4"}},{"id":1543691,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-10T20:35:01.000Z","date":"2024-04-08","kind":"sale","planned":true,"acquired":false,"shares":820,"price":20.453,"value":16771.46,"ownership":{"direct":false,"nature":"By Annette Bradbury Irrecovable Descendant's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on August 23, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $20.345 to $20.570, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Held by Annette Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries."}],"balance_after":17948,"source":{"system":"sec-edgar","filing":"0001447362-24-000048","document":"wk-form4_1712781290.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736224000048/wk-form4_1712781290.xml","form_type":"4"}},{"id":1543690,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-10T20:35:01.000Z","date":"2024-04-08","kind":"sale","planned":true,"acquired":false,"shares":819,"price":20.453,"value":16751.007,"ownership":{"direct":false,"nature":"By Daniel Bradbury Irrecovable Descendant's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on August 23, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $20.345 to $20.570, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Held by Daniel Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries."}],"balance_after":17944,"source":{"system":"sec-edgar","filing":"0001447362-24-000048","document":"wk-form4_1712781290.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736224000048/wk-form4_1712781290.xml","form_type":"4"}},{"id":1543689,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-10T20:35:01.000Z","date":"2024-04-08","kind":"sale","planned":true,"acquired":false,"shares":761,"price":20.453,"value":15564.733,"ownership":{"direct":false,"nature":"By LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on August 23, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $20.345 to $20.570, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Held by BioBrit, LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares."}],"balance_after":42516,"source":{"system":"sec-edgar","filing":"0001447362-24-000048","document":"wk-form4_1712781290.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736224000048/wk-form4_1712781290.xml","form_type":"4"}},{"id":1545485,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-08T20:31:47.000Z","date":"2024-04-05","kind":"sale","planned":true,"acquired":false,"shares":4021,"price":20.86,"value":83878.06,"ownership":{"direct":false,"nature":"By Annette Bradbury Irrecovable Descendant's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on August 22, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $20.76 to $21.23, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Held by Annette Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries."}],"balance_after":18768,"source":{"system":"sec-edgar","filing":"0001447362-24-000037","document":"wk-form4_1712608298.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736224000037/wk-form4_1712608298.xml","form_type":"4"}},{"id":1545484,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-08T20:31:47.000Z","date":"2024-04-05","kind":"sale","planned":true,"acquired":false,"shares":4019,"price":20.86,"value":83836.34,"ownership":{"direct":false,"nature":"By Daniel Bradbury Irrecovable Descendant's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on August 22, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $20.76 to $21.23, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Held by Daniel Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries."}],"balance_after":18763,"source":{"system":"sec-edgar","filing":"0001447362-24-000037","document":"wk-form4_1712608298.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736224000037/wk-form4_1712608298.xml","form_type":"4"}},{"id":1545483,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-08T20:31:47.000Z","date":"2024-04-05","kind":"sale","planned":true,"acquired":false,"shares":3731,"price":20.86,"value":77828.66,"ownership":{"direct":false,"nature":"By LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on August 22, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $20.76 to $21.23, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Held by BioBrit, LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares."}],"balance_after":43277,"source":{"system":"sec-edgar","filing":"0001447362-24-000037","document":"wk-form4_1712608298.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736224000037/wk-form4_1712608298.xml","form_type":"4"}},{"id":1545482,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-08T20:31:47.000Z","date":"2024-04-04","kind":"sale","planned":true,"acquired":false,"shares":3126,"price":21.45,"value":67052.7,"ownership":{"direct":false,"nature":"By Annette Bradbury Irrecovable Descendant's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on August 22, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $21.18 to $21.84, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Held by Annette Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries."}],"balance_after":22789,"source":{"system":"sec-edgar","filing":"0001447362-24-000037","document":"wk-form4_1712608298.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736224000037/wk-form4_1712608298.xml","form_type":"4"}},{"id":1545481,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-08T20:31:47.000Z","date":"2024-04-04","kind":"sale","planned":true,"acquired":false,"shares":3125,"price":21.45,"value":67031.25,"ownership":{"direct":false,"nature":"By Daniel Bradbury Irrecovable Descendant's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on August 22, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $21.18 to $21.84, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Held by Daniel Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries."}],"balance_after":22782,"source":{"system":"sec-edgar","filing":"0001447362-24-000037","document":"wk-form4_1712608298.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736224000037/wk-form4_1712608298.xml","form_type":"4"}},{"id":1545480,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-08T20:31:47.000Z","date":"2024-04-04","kind":"sale","planned":true,"acquired":false,"shares":2901,"price":21.45,"value":62226.45,"ownership":{"direct":false,"nature":"By LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on August 22, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $21.18 to $21.84, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Held by BioBrit, LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares."}],"balance_after":47008,"source":{"system":"sec-edgar","filing":"0001447362-24-000037","document":"wk-form4_1712608298.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736224000037/wk-form4_1712608298.xml","form_type":"4"}},{"id":1557496,"issuer":{"id":6636,"kind":"organization","name":"Vivani Medical, Inc."},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-03-29T22:24:27.000Z","date":"2024-03-27","kind":"grant","planned":false,"acquired":true,"shares":26145,"price":1.43,"value":37387.35,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Awarded pursuant to the Issuer's non-employee director compensation policy in lieu of pro-rated cash retainer fees of $37,500."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options have a 10-year term and vests quarterly through December 31, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Awarded pursuant to the Issuer's non-employee director compensation policy in lieu of pro-rated cash retainer fees of $37,500."}],"balance_after":26145,"derivative":{"exercise_price":1.85,"expiration_date":"2034-03-26","underlying":"Common Stock","underlying_shares":26145},"source":{"system":"sec-edgar","filing":"0001753926-24-000644","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266806/000175392624000644/ownership.xml","form_type":"4"}},{"id":1559395,"issuer":{"id":6636,"kind":"organization","name":"Vivani Medical, Inc."},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-03-28T01:00:55.000Z","date":"2024-03-25","kind":"grant","planned":false,"acquired":true,"shares":22869,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options have a 10-year term and vest monthly equally over three years."}],"balance_after":22869,"derivative":{"exercise_price":1.92,"expiration_date":"2034-03-24","underlying":"Common Stock","underlying_shares":22869},"source":{"system":"sec-edgar","filing":"0001753926-24-000622","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266806/000175392624000622/ownership.xml","form_type":"4"}},{"id":1591494,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-06T22:52:27.000Z","date":"2024-03-04","kind":"sale","planned":true,"acquired":false,"shares":2262,"price":21.28,"value":48135.36,"ownership":{"direct":false,"nature":"By Annette Bradbury Irrecovable Descendant's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on August 22, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $21.05 to $21.43, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Held by Annette Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries."}],"balance_after":25915,"source":{"system":"sec-edgar","filing":"0001447362-24-000019","document":"wk-form4_1709765534.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736224000019/wk-form4_1709765534.xml","form_type":"4"}},{"id":1591493,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-06T22:52:27.000Z","date":"2024-03-04","kind":"sale","planned":true,"acquired":false,"shares":2262,"price":21.28,"value":48135.36,"ownership":{"direct":false,"nature":"By Daniel Bradbury Irrecovable Descendant's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on August 22, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $21.05 to $21.43, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Held by Daniel Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries."}],"balance_after":25907,"source":{"system":"sec-edgar","filing":"0001447362-24-000019","document":"wk-form4_1709765534.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736224000019/wk-form4_1709765534.xml","form_type":"4"}},{"id":1591492,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-06T22:52:27.000Z","date":"2024-03-04","kind":"sale","planned":true,"acquired":false,"shares":2099,"price":21.28,"value":44666.72,"ownership":{"direct":false,"nature":"By LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on August 22, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $21.05 to $21.43, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Held by BioBrit, LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares."}],"balance_after":49909,"source":{"system":"sec-edgar","filing":"0001447362-24-000019","document":"wk-form4_1709765534.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736224000019/wk-form4_1709765534.xml","form_type":"4"}},{"id":1591491,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-06T22:52:27.000Z","date":"2024-03-04","kind":"sale","planned":true,"acquired":false,"shares":5705,"price":20.44,"value":116610.2,"ownership":{"direct":false,"nature":"By Annette Bradbury Irrecovable Descendant's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on August 22, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $20.03 to $20.99, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Held by Annette Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries."}],"balance_after":28177,"source":{"system":"sec-edgar","filing":"0001447362-24-000019","document":"wk-form4_1709765534.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736224000019/wk-form4_1709765534.xml","form_type":"4"}},{"id":1591490,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-06T22:52:27.000Z","date":"2024-03-04","kind":"sale","planned":true,"acquired":false,"shares":5701,"price":20.44,"value":116528.44,"ownership":{"direct":false,"nature":"By Daniel Bradbury Irrecovable Descendant's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on August 22, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $20.03 to $20.99, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Held by Daniel Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries."}],"balance_after":28169,"source":{"system":"sec-edgar","filing":"0001447362-24-000019","document":"wk-form4_1709765534.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736224000019/wk-form4_1709765534.xml","form_type":"4"}},{"id":1591489,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-06T22:52:27.000Z","date":"2024-03-04","kind":"sale","planned":true,"acquired":false,"shares":5294,"price":20.44,"value":108209.36,"ownership":{"direct":false,"nature":"By LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on August 22, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $20.03 to $20.99, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Held by BioBrit, LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares."}],"balance_after":52008,"source":{"system":"sec-edgar","filing":"0001447362-24-000019","document":"wk-form4_1709765534.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736224000019/wk-form4_1709765534.xml","form_type":"4"}},{"id":1651508,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-09T21:49:06.000Z","date":"2024-02-07","kind":"sale","planned":true,"acquired":false,"shares":708,"price":23.2,"value":16425.6,"ownership":{"direct":false,"nature":"By Annette Bradbury Irrecovable Descendant's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on August 22, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $23.05 to $23.71, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Held by Annette Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries."}],"balance_after":33882,"source":{"system":"sec-edgar","filing":"0001447362-24-000012","document":"wk-form4_1707515336.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736224000012/wk-form4_1707515336.xml","form_type":"4"}},{"id":1651507,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-09T21:49:06.000Z","date":"2024-02-07","kind":"sale","planned":true,"acquired":false,"shares":708,"price":23.2,"value":16425.6,"ownership":{"direct":false,"nature":"By Daniel Bradbury Irrecovable Descendant's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on August 22, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $23.05 to $23.71, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Held by Daniel Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries."}],"balance_after":33870,"source":{"system":"sec-edgar","filing":"0001447362-24-000012","document":"wk-form4_1707515336.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736224000012/wk-form4_1707515336.xml","form_type":"4"}},{"id":1651506,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-09T21:49:06.000Z","date":"2024-02-07","kind":"sale","planned":true,"acquired":false,"shares":658,"price":23.2,"value":15265.6,"ownership":{"direct":false,"nature":"By LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on August 22, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $23.05 to $23.71, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Held by BioBrit, LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares."}],"balance_after":57302,"source":{"system":"sec-edgar","filing":"0001447362-24-000012","document":"wk-form4_1707515336.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736224000012/wk-form4_1707515336.xml","form_type":"4"}},{"id":1655207,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-07T21:19:09.000Z","date":"2024-02-06","kind":"sale","planned":true,"acquired":false,"shares":3364,"price":23.63,"value":79491.32,"ownership":{"direct":false,"nature":"By Annette Bradbury Irrecovable Descendant's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on August 22, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $23.22 to $23.95, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Held by Annette Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries."}],"balance_after":34590,"source":{"system":"sec-edgar","filing":"0001447362-24-000010","document":"wk-form4_1707340729.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736224000010/wk-form4_1707340729.xml","form_type":"4"}},{"id":1655206,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-07T21:19:09.000Z","date":"2024-02-06","kind":"sale","planned":true,"acquired":false,"shares":3362,"price":23.63,"value":79444.06,"ownership":{"direct":false,"nature":"By Daniel Bradbury Irrecovable Descendant's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on August 22, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $23.22 to $23.95, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Held by Daniel Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries."}],"balance_after":34578,"source":{"system":"sec-edgar","filing":"0001447362-24-000010","document":"wk-form4_1707340729.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736224000010/wk-form4_1707340729.xml","form_type":"4"}},{"id":1655205,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-07T21:19:09.000Z","date":"2024-02-06","kind":"sale","planned":true,"acquired":false,"shares":3121,"price":23.63,"value":73749.23,"ownership":{"direct":false,"nature":"By LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on August 22, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $23.22 to $23.95, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Held by BioBrit, LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares."}],"balance_after":57960,"source":{"system":"sec-edgar","filing":"0001447362-24-000010","document":"wk-form4_1707340729.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736224000010/wk-form4_1707340729.xml","form_type":"4"}},{"id":1655204,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-07T21:19:09.000Z","date":"2024-02-05","kind":"sale","planned":true,"acquired":false,"shares":931,"price":23.42,"value":21804.02,"ownership":{"direct":false,"nature":"By Annette Bradbury Irrecovable Descendant's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on August 22, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $23.33 to $23.53, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Held by Annette Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries."}],"balance_after":37954,"source":{"system":"sec-edgar","filing":"0001447362-24-000010","document":"wk-form4_1707340729.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736224000010/wk-form4_1707340729.xml","form_type":"4"}},{"id":1655203,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-07T21:19:09.000Z","date":"2024-02-05","kind":"sale","planned":true,"acquired":false,"shares":930,"price":23.42,"value":21780.6,"ownership":{"direct":false,"nature":"By Daniel Bradbury Irrecovable Descendant's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on August 22, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $23.33 to $23.53, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Held by Daniel Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries."}],"balance_after":37940,"source":{"system":"sec-edgar","filing":"0001447362-24-000010","document":"wk-form4_1707340729.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736224000010/wk-form4_1707340729.xml","form_type":"4"}},{"id":1655202,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-07T21:19:09.000Z","date":"2024-02-05","kind":"sale","planned":true,"acquired":false,"shares":863,"price":23.42,"value":20211.46,"ownership":{"direct":false,"nature":"By LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on August 22, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $23.33 to $23.53, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Held by BioBrit, LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares."}],"balance_after":61081,"source":{"system":"sec-edgar","filing":"0001447362-24-000010","document":"wk-form4_1707340729.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736224000010/wk-form4_1707340729.xml","form_type":"4"}},{"id":1655201,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-07T21:19:09.000Z","date":"2024-02-05","kind":"sale","planned":true,"acquired":false,"shares":2964,"price":22.74,"value":67401.36,"ownership":{"direct":false,"nature":"By Annette Bradbury Irrecovable Descendant's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on August 22, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $22.33 to $23.32, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Held by Annette Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries."}],"balance_after":38885,"source":{"system":"sec-edgar","filing":"0001447362-24-000010","document":"wk-form4_1707340729.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736224000010/wk-form4_1707340729.xml","form_type":"4"}},{"id":1655200,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-07T21:19:09.000Z","date":"2024-02-05","kind":"sale","planned":true,"acquired":false,"shares":2963,"price":22.74,"value":67378.62,"ownership":{"direct":false,"nature":"By Daniel Bradbury Irrecovable Descendant's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on August 22, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $22.33 to $23.32, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Held by Daniel Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries."}],"balance_after":38870,"source":{"system":"sec-edgar","filing":"0001447362-24-000010","document":"wk-form4_1707340729.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736224000010/wk-form4_1707340729.xml","form_type":"4"}},{"id":1655199,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-07T21:19:09.000Z","date":"2024-02-05","kind":"sale","planned":true,"acquired":false,"shares":2751,"price":22.74,"value":62557.74,"ownership":{"direct":false,"nature":"By LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on August 22, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $22.33 to $23.32, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Held by BioBrit, LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares."}],"balance_after":61944,"source":{"system":"sec-edgar","filing":"0001447362-24-000010","document":"wk-form4_1707340729.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736224000010/wk-form4_1707340729.xml","form_type":"4"}},{"id":1684106,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-08T21:19:09.000Z","date":"2024-01-05","kind":"sale","planned":true,"acquired":false,"shares":1742,"price":20.36,"value":35467.12,"ownership":{"direct":false,"nature":"By Annette Bradbury Irrecovable Descendant's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on August 22, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $20.05 to $20.62, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Held by Annette Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries."}],"balance_after":41849,"source":{"system":"sec-edgar","filing":"0001447362-24-000008","document":"wk-form4_1704748739.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736224000008/wk-form4_1704748739.xml","form_type":"4"}},{"id":1684105,"issuer":{"id":359,"kind":"organization","name":"CASTLE BIOSCIENCES INC","symbol":"CSTL"},"owners":[{"id":28241,"kind":"person","name":"BRADBURY DANIEL","position":1,"cik":"0001236397","reported_name":"BRADBURY DANIEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-08T21:19:09.000Z","date":"2024-01-05","kind":"sale","planned":true,"acquired":false,"shares":1741,"price":20.36,"value":35446.76,"ownership":{"direct":false,"nature":"By Daniel Bradbury Irrecovable Descendant's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on August 22, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $20.05 to $20.62, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Held by Daniel Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries."}],"balance_after":41833,"source":{"system":"sec-edgar","filing":"0001447362-24-000008","document":"wk-form4_1704748739.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1447362/000144736224000008/wk-form4_1704748739.xml","form_type":"4"}}],"next_cursor":"2024-01-08T21:19:09.000000Z,1684105"}